Evidence map›Paper›PMID 18347936›Full record

ReviewCell stress & chaperones2008

The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells.

Mathias Gehrmann, Jürgen Radons, Michael Molls, Gabriele Multhoff

Open access · greenAbstract readReview
In one paragraph

Review in Cell stress & chaperones, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 58 citations in OpenAlex.

  1. Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagus.European journal of nuclear medicine and molecular imaging · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mathias GehrmannDepartment of Radiotherapy and Radiooncology and Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH)-Institute of Pathology, University Hospital rechts der Isar, Technische Universität München, Ismaningerstrasse 22, Munich, Germany.
Jürgen Radons
Michael Molls
Gabriele Multhoff
Technical University of Munich · DEHelmholtz Zentrum München · DEUniversität Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence that membrane-bound and extracellular heat shock proteins (HSPs) with molecular weights of 70 and 90 kDa are potent stimulators of the immune responses has accumulated over the last decade. In this review, we discuss the modulation of Hsp70 expression, a major stress-inducible member of the HSP70 family, in the cytoplasm and on the plasma membrane of tumor cells by clinically applied interventions such as radio- and chemotherapy.

Indexed as

Amino Acid SequenceAnimalsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsCell DifferentiationGene Expression Regulation, NeoplasticHSP70 Heat-Shock ProteinsHumansMembrane ProteinsMiceMice, Mutant StrainsMice, SCIDMolecular Sequence DataMultigene FamilyNeoplasm ProteinsNeoplasmsAnti-Inflammatory Agents, Non-SteroidalAntineoplastic AgentsHSP70 Heat-Shock ProteinsMembrane ProteinsNeoplasm ProteinsPeptide FragmentsTretinoin

Identifiers

PMID18347936
PMCPMC2666213
OpenAlexW2017476164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.